Amity Institute of Biotechnology, Amity University Madhya Pradesh, Gwalior (M.P.), India.
Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 712-749, South Korea.
Curr Pharm Des. 2020;26(38):4909-4916. doi: 10.2174/1381612826666200826135401.
For improvisation of diabetic's quality of life, nanotechnology is facilitating the development of advanced glucose sensors as well as efficient insulin delivery systems. Our prime focus of the review is to highlight the advancement in diabetic research with special reference to nanotechnology at its interface. Recent studies are more focused on enhancing sensitivity, accuracy, and response by employing metal as well as nanoparticles based glucose sensors. Moreover, the review focuses on nanoscale based approaches i.e. closed-loop insulin delivery systems, which detect any fluctuation in blood glucose levels and allow controlled release of a drug, thus are also called self-regulating insulin release system. Additionally, this review summarizes the role of nanotechnology in the diagnosis and treatment of diabetic complications through little advancement in the existing techniques. To improve health, as well as the quality of life in diabetic's new sensing systems for blood glucose level evaluation and controlled administration of drugs through efficient drug delivery systems should be explored.
为了提高糖尿病患者的生活质量,纳米技术正在促进先进葡萄糖传感器以及高效胰岛素输送系统的发展。我们的主要关注点是突出糖尿病研究方面的进展,特别提到纳米技术在其中的应用。最近的研究更侧重于通过使用金属和基于纳米粒子的葡萄糖传感器来提高传感器的灵敏度、准确性和响应性。此外,该综述还重点介绍了基于纳米尺度的方法,即闭环胰岛素输送系统,它可以检测到血糖水平的任何波动,并允许药物的受控释放,因此也被称为自调节胰岛素释放系统。此外,本综述通过现有技术的微小进步,总结了纳米技术在糖尿病并发症的诊断和治疗中的作用。为了改善糖尿病患者的健康和生活质量,应该探索用于评估血糖水平和通过高效药物输送系统控制药物给药的新型传感系统。